A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Claude Houdayer(Inserm), Jonathan J. Morrison(Uniformed Services University of the Health Sciences), Antonis C. Antoniou(Weatherford College), Daniel Barrowdale(University of Cambridge), Christiana Kartsonaki(University of Oxford), Timothy G. Lesnick(Mayo Clinic in Florida), Olivier Caron(Université Paris-Saclay), Maya Ghoussaini(Regeneron (United States)), Audrey Remenieras, Carol Chu(Lyon 1 Université), Dominique Stoppa‐Lyonnet(Centre National de la Recherche Scientifique), Xianshu Wang(Kunming University of Science and Technology), D. Gareth Evans(Manchester Academic Health Science Centre), Robert F. Tarrell(University of Cambridge), Margaret Cook(The University of Queensland), Louise Izatt(Guy's Hospital), Zachary S. Fredericksen(Leiden University), Pascaline Berthet(Centre François Baclesse), Sophie Giraud(Hospices Civils de Lyon), Clare Oliver, Fiona Douglas(University of Southern California), Lesley McGuffog(University of Cambridge), Christine Lasset(Centre National de la Recherche Scientifique), Sue Healey(QIMR Berghofer Medical Research Institute), Joan Paterson, Susan Peock(Cancer Research UK), Olga M. Sinilnikova(Hospices Civils de Lyon), Agnès Hardouin(University Medical Center Utrecht), Debra Frost(University of Cambridge), Sylvie Mazoyer(Université Claude Bernard Lyon 1), Diana Eccles(Princess Anne Hospital), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust)
UNC Libraries
November 6, 2020
Cited by 0


Related Papers